Director, CEO and founder of Sygnature Discovery

Simon is Sygnature’s Founder, Chief Executive Officer and chair of the Board of Directors. He is a medicinal chemist with 30 years’ experience in the pharmaceutical industry. Simon has been engaged in the full spectrum of drug discovery programmes – from hit to lead libraries, hit-to-lead campaigns, all the way to successful lead optimisation projects and candidate drug selection.

He has broad-ranging experience of research in a large pharmaceutical company (AstraZeneca), a mid-size biotech (OSI Pharmaceuticals); as well as in a more commercial environment at CombiPure Ltd., where he was Managing Director and Director of Chemistry. Simon has a BSc (Hons.) in chemistry and a PhD in synthetic organic chemistry from the University of Nottingham, and undertook post-doctoral research at the University of Pittsburgh.